HALOZYME THERAPEUTICS INC
HALONASDAQ🏆 #728 by market capEarnings Nov 2US Equity
$111.56▼ $1.32 (−1.18%)
🌙 After hours$111.56▲ 0.00%Regular close · extended-hours price shownTrack HALO
Get earnings, price moves & breaking news on Telegram
24h▼ 1.2%
7d▼ 3.1%
14d▲ 4.9%
30d▲ 5.9%
ytd▲ 65.8%
1y▲ 52.3%
🏦Market Cap
$13.23B
Mid Cap
📈Revenue Growth (YoY)
+37.5%
High Growth
📊Gross Margin
78.2%
High
💵FCF Margin
48.5%
Strong
⚖️P/S Ratio
8.0x
Elevated
Otter Score
88
Very Good
HALOZYME THERAPEUTICS INC
HALOAnalyst Ratings
Price
$111.56
Total
27
Raised
2
Lowered
2
Avg PT
$103.00
H / L
$115 / $90
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-02 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2026-08-07 | $95.00 | −14.80% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2026-08-07 | $110.00 | −1.40% |
Citizens | Reiterated | Market Outperform | 2026-08-07 | — | — |
TD Cowen | Reiterated | Buy | 2026-08-07 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-05-12 | $105.00 | −5.90% |
Benchmark | Reiterated | Buy | 2026-02-19 | — | — |
Goldman Sachs | Reiterated | Neutral | 2025-11-18 | $56.00 | −49.80% |
JP Morgan | Reiterated | Neutral | 2025-10-27 | $54.00 | −51.60% |
JMP Securities | Reiterated | Market Outperform | 2025-08-06 | $92.00 | −17.50% |
Piper Sandler | Reiterated | Neutral | 2025-01-10 | $52.00 | −53.40% |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-03-16 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2021-06-14 | — | — |
Berenberg | Reiterated | Buy | 2020-12-17 | — | — |
Citigroup | Reiterated | Neutral | 2020-06-15 | — | — |
Canaccord Genuity | Reiterated | Buy | 2020-05-19 | — | — |
BMO Capital | Reiterated | Outperform | 2020-05-12 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2020-05-04 | — | — |
Barclays | Reiterated | Equal Weight | 2020-02-25 | — | — |
Deutsche Bank | Reiterated | Buy | 2016-11-03 | — | — |
PiperJaffray | Reiterated | Overweight | 2016-09-16 | — | — |
MLV & Co. | Reiterated | Buy | 2014-12-24 | — | — |
Jefferies | Reiterated | Underperform | 2014-09-15 | — | — |
UBS | Upgraded | Neutral → Buy | 2014-06-11 | $90.00 | −19.30% |
Wedbush | Downgraded | Outperform → Neutral | 2013-01-30 | — | — |
Brean Capital | Reiterated | Buy | 2012-04-16 | — | — |
Oppenheimer | Reiterated | Outperform | 2012-04-16 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-02
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-08-07
$95.00
−14.80%
Leerink Partners
Upgraded · Market Perform → Outperform · 2026-08-07
$110.00
−1.40%
Citizens
Reiterated · Market Outperform · 2026-08-07
—
—
TD Cowen
Reiterated · Buy · 2026-08-07
—
—
Morgan Stanley
Reiterated · Overweight · 2026-05-12
$105.00
−5.90%
Benchmark
Reiterated · Buy · 2026-02-19
—
—
Goldman Sachs
Reiterated · Neutral · 2025-11-18
$56.00
−49.80%
JP Morgan
Reiterated · Neutral · 2025-10-27
$54.00
−51.60%
JMP Securities
Reiterated · Market Outperform · 2025-08-06
$92.00
−17.50%
Piper Sandler
Reiterated · Neutral · 2025-01-10
$52.00
−53.40%
SVB Leerink
Downgraded · Outperform → Market Perform · 2023-03-16
—
—
Evercore ISI Group
Reiterated · Outperform · 2021-06-14
—
—
Berenberg
Reiterated · Buy · 2020-12-17
—
—
Citigroup
Reiterated · Neutral · 2020-06-15
—
—
Canaccord Genuity
Reiterated · Buy · 2020-05-19
—
—
BMO Capital
Reiterated · Outperform · 2020-05-12
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2020-05-04
—
—
Barclays
Reiterated · Equal Weight · 2020-02-25
—
—
Deutsche Bank
Reiterated · Buy · 2016-11-03
—
—
PiperJaffray
Reiterated · Overweight · 2016-09-16
—
—
MLV & Co.
Reiterated · Buy · 2014-12-24
—
—
Jefferies
Reiterated · Underperform · 2014-09-15
—
—
UBS
Upgraded · Neutral → Buy · 2014-06-11
$90.00
−19.30%
Wedbush
Downgraded · Outperform → Neutral · 2013-01-30
—
—
Brean Capital
Reiterated · Buy · 2012-04-16
—
—
Oppenheimer
Reiterated · Outperform · 2012-04-16
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space